Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02861573
Title Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NZL | NLD | ITA | GBR | FRA | ESP | DEU | CAN | AUT | AUS

Facility Status City State Zip Country Details
Call for Information (Investigational Site 2086) RECRUITING Los Angeles California 90073 United States Details
Call for Information (Investigational Site 0007) RECRUITING Orange California 92868 United States Details
Call for Information (Investigational Site 2041) RECRUITING Aurora Colorado 80045 United States Details
Call for Information (Investigational Site 2018) RECRUITING Washington District of Columbia 20007 United States Details
Call for Information (Investigational Site 0010) RECRUITING Chicago Illinois 60607 United States Details
Call for Information (Investigational Site 2083) RECRUITING Baltimore Maryland 21201 United States Details
Call for Information (Investigational Site 0004) RECRUITING Cary North Carolina 27518 United States Details
Call for Information (Investigational Site 2091) RECRUITING Cleveland Ohio 44195 United States Details
Call for Information (Investigational Site 2027) RECRUITING Portland Oregon 97239 United States Details
Call for Information (Investigational Site 2094) RECRUITING Portland Oregon 97239 United States Details
Call for Information (Investigational Site 0008) RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Call for Information (Investigational Site 2065) RECRUITING Charleston South Carolina 29401 United States Details
Call for Information (Investigational Site 2090) RECRUITING Germantown Tennessee 38138 United States Details
Call for Information (Investigational Site 0016) RECRUITING Seattle Washington 98109 United States Details
MSD Australia RECRUITING North Ryde Australia Details
MSD Osterreich GmbH RECRUITING Vienna Austria Details
Merck Canada RECRUITING Kirkland Quebec H9H 4M7 Canada Details
MSD Denmark RECRUITING Glostrup Denmark Details
MSD Finland Oy RECRUITING Espoo Finland Details
MSD France RECRUITING Paris France Details
MSD Sharp & Dohme GmbH RECRUITING Haar Germany Details
MSD Ireland (Human Health) Ltd. RECRUITING Dublin Ireland Details
MSD Italia S.r.l. RECRUITING Rome Italy Details
MSD RECRUITING Mexico City Mexico Details
Merck Sharp & Dohme BV RECRUITING Haarlem Netherlands Details
Merck Sharp & Dohme (New Zealand) Ltd., RECRUITING Auckland New Zealand Details
MSD Polska Sp. Z o.o. RECRUITING Warsaw Poland Details
Merck Sharp & Dohme IDEA, Inc. RECRUITING Moscow Russian Federation Details
Merck Sharp and Dohme de Espana S.A. RECRUITING Madrid Spain Details
MSD Sweden RECRUITING Stockholm Sweden Details
Merck Sharp & Dohme (I.A.) Corp. RECRUITING Taipei Taiwan Details
Merck Sharp & Dohme Ilaclari Ltd. Sti RECRUITING Istanbul Turkey Details
MSD Ukraine LLC RECRUITING Kiev Ukraine Details
Merck Sharp & Dohme Ltd. RECRUITING Hoddesdon United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field